UT Health Science Center researchers use ‘brain-on-a-chip’ to revolutionize fight against deadly encephalitis viruses
Grant and Award Announcement
Updates every hour. Last Updated: 22-Dec-2025 11:11 ET (22-Dec-2025 16:11 GMT/UTC)
A recent review, led by researchers from the Stanford Department of Cardiothoracic Surgery in collaboration with Germany's Helios Hospital, examines the current state, challenges, and future directions of adult heart transplantation in its two highest-volume regions – the United States and Western Europe. While both areas have achieved remarkable success, they have embraced varying approaches in their transplantation systems, shaped by the cultural and political attitudes of the region.
Mass General Brigham study found nearly a fourfold increase in cannabis use among adolescents in Massachusetts presenting for psychiatric emergency services after commercialization
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors—such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)—or glucagon-like peptide-1 (GLP-1) receptor agonists—such as semaglutide (Ozempic) and liraglutide (Victoza)—experience slower progression of frailty over one year compared with those starting other diabetes medications. The findings suggest these therapies could help older adults maintain strength, mobility, and independence beyond their well-known effects on blood sugar and heart health.